Abstract

Six asymmetric ligands, 6-[(4,5-diazafluoren-9-ylimino)methyoxyphenyl]-2,2′-bipyridine (L1), 4-[(4,5-diazafluoren-9-ylimino)methyoxyphenyl]-6-phenyl-2,2′-bipyridine (L2), 6-[4-(4,5-diazafluoren-9-ylimino)phenoxybenzyl]-2,2′-bipyridine (L3), 4-[4-(4,5-diazafluoren-9-ylimino)phenoxybenzyl]-6-phenyl-2,2′-bipyridine (L4), 6-[2-(4,5-diazafluoren-9-ylimino)phenoxybenzyl]-2,2′-bipyridine (L5) and 4-[2-(4,5-diazafluoren-9-ylimino)phenoxybenzyl]-6-phenyl-2,2′-bipyridine (L6), and corresponding Ru(II) complexes [(bpy)2Ru(L1–6)](PF6)2 (bpy = 2,2′-bipyridine) were synthesized. All six ligands have two kinds of nonequivalent chelating sites: one involving the 6-phenyl substituted 2,2′-bipyridine moiety, and the other involving the 4,5-diazafluorene moiety. All six Ru(II) complexes have metal-to-ligand charge transfer absorptions around 447 nm and one Ru(II)-centered oxidation around 1.35 V versus SCE in CH3CN solution at room temperature. These complexes are non-emissive in CH3CN solution at room temperature. The emission intensities of [(bpy)2Ru(L1)]2+ and [(bpy)2Ru(L2)]2+ are stronger than that of [(bpy)2Ru(L3–6)]2+ in EtOH-MeOH (4 : 1, v/v) glassy matrix at 77 K.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.